Phase I trials of GBR 401 for leukaemia and lymphoma of B-cell origin planned.
Latest Information Update: 04 Apr 2011
At a glance
- Drugs GBR 401 (Primary)
- Indications Leukaemia; Lymphoma
- Focus Adverse reactions
- 04 Apr 2011 New trial record
Latest Information Update: 04 Apr 2011